$101.98
3.19% day before yesterday
Nasdaq, Sep 06, 10:00 pm CET
ISIN
US5165441032
Symbol
LNTH

Lantheus Holdings Inc Stock price

$101.98
+3.83 3.90% 1M
+40.01 64.56% 6M
+39.98 64.48% YTD
+35.25 52.82% 1Y
+74.83 275.62% 3Y
+79.47 353.04% 5Y
+95.21 1,406.35% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
-3.36 3.19%
ISIN
US5165441032
Symbol
LNTH
Sector

Key metrics

Market capitalization $7.08b
Enterprise Value $6.94b
P/E (TTM) P/E ratio 16.70
EV/FCF (TTM) EV/FCF 17.59
EV/Sales (TTM) EV/Sales 4.83
P/S ratio (TTM) P/S ratio 4.92
P/B ratio (TTM) P/B ratio 7.03
Revenue growth (TTM) Revenue growth 27.83%
Revenue (TTM) Revenue $1.44b
EBIT (operating result TTM) EBIT $452.56m
Free Cash Flow (TTM) Free Cash Flow $394.85m
Cash position $757.02m
EPS (TTM) EPS $6.11
P/E forward 18.42
P/S forward 4.66
EV/Sales forward 4.57
Short interest 7.11%
Show more

Is Lantheus Holdings Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Lantheus Holdings Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Lantheus Holdings Inc forecast:

11x Buy
92%
1x Hold
8%

Analyst Opinions

12 Analysts have issued a Lantheus Holdings Inc forecast:

Buy
92%
Hold
8%

Financial data from Lantheus Holdings Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
1,438 1,438
28% 28%
100%
- Direct Costs 511 511
30% 30%
36%
927 927
27% 27%
64%
- Selling and Administrative Expenses 275 275
52% 52%
19%
- Research and Development Expense 140 140
58% 58%
10%
512 512
133% 133%
36%
- Depreciation and Amortization 60 60
10% 10%
4%
EBIT (Operating Income) EBIT 453 453
173% 173%
31%
Net Profit 428 428
1,184% 1,184%
30%

In millions USD.

Don't miss a Thing! We will send you all news about Lantheus Holdings Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Lantheus Holdings Inc Stock News

Neutral
GlobeNewsWire
2 days ago
BEDFORD, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced the appointment of Julie Eastland, an experienced biotechnology and financial executive, to Lantheus' Board of Directors (“Boa...
Neutral
GlobeNewsWire
10 days ago
BEDFORD, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Brian Markison, Chief Executive Officer, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference at 7:45 a....
Positive
Seeking Alpha
26 days ago
PYLARIFY is the leading PSMA PET imaging agent, on track to surpass $1 billion in sales by 2024, driving significant revenue growth for Lantheus Holdings, Inc. Lantheus is heavily investing in its oncology and Alzheimer's diagnostics pipeline, positioning itself for substantial long-term growth despite short-term profit impacts. With robust free cash flow, a solid balance sheet, and potential f...
More Lantheus Holdings Inc News

Company Profile

Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. The firm operates through the following geographical segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sells its products to radio pharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 1956 and is headquartered in North Billerica, MA.

Head office United States
CEO Brian Markison
Employees 834
Founded 1956
Website www.lantheus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today